Diagnostic applications of nuclear medicine: Ovarian cancer Book Section
| Authors: | Pandit-Taskar, N.; Mahajan, S.; Ma, W. |
| Editors: | Volterrani, D.; Erba, P. A.; Strauss, H. W.; Mariani, G.; Larson, S. M. |
| Article/Chapter Title: | Diagnostic applications of nuclear medicine: Ovarian cancer |
| Abstract: | Ovarian malignancies are a leading cause of death in women in the United States and a significant health issue for women worldwide. Anatomic imaging with ultrasound, computed tomography, and magnetic resonance is a main tool for the diagnosis, staging, and follow-up of recurrent disease; however, it lacks biologic information. Nuclear imaging, primarily positron emission tomography/computed tomography (PET/CT) with 2-deoxy-2-[18F]fluoro-d-glucose ([18F]FDG), has been increasingly used for the detection of cancer. Encouraging data have emerged in recent years that support the use of [18F]FDG PET/CT in a variety of clinical settings in ovarian cancer management. © Springer Nature Switzerland AG 2022. |
| Keywords: | staging; ovarian cancer; imaging; response to therapy; prognosis; [18f]fdg pet/ct |
| Book Title: | Nuclear Oncology: From Pathophysiology to Clinical Applications. 3rd ed |
| ISBN: | 978-3-031-05493-8 |
| Publisher: | Springer |
| Publication Place: | Cham, Switzerland |
| Date Published: | 2022-01-01 |
| Start Page: | 1185 |
| End Page: | 1212 |
| Language: | English |
| DOI: | 10.1007/978-3-031-05494-5_46 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Book Chapter: 37, in the section "Part II - Diagnostic Applications of Nuclear Medicine" (Volume 2) -- Export Date: 1 June 2023 -- Source: Scopus |
